KRANESHARES TRUST - MSCI EMG EX CH (KEMX) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2019 to Q4 2025

Type / Class
Equity / MSCI EMG EX CH
Symbol
KEMX
Price per share
$37.17
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
974,258
Total reported value
$33,714,122
% of total 13F portfolios
0%
Share change
+38,466
Value change
+$1,331,285
Number of holders
21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 21 institutional investors reported holding 974,258 shares of KRANESHARES TRUST - MSCI EMG EX CH (KEMX).

Institutional Holders of KRANESHARES TRUST - MSCI EMG EX CH (KEMX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$866 $37.17 0
2025 Q3 974,258 $33,714,122 +$1,331,285 $34.61 21
2025 Q2 935,793 $30,178,892 -$10,249,918 $32.25 16
2025 Q1 1,271,050 $35,433,617 -$2,160,205 $27.88 16
2024 Q4 1,349,134 $37,389,124 +$2,153,914 $27.71 20
2024 Q3 1,266,284 $39,544,348 -$1,470,301 $31.21 19
2024 Q2 1,316,645 $39,553,119 +$5,989,967 $30.04 21
2024 Q1 1,121,080 $32,876,576 +$6,332,322 $29.33 26
2023 Q4 905,791 $25,825,793 +$4,847,889 $28.51 17
2023 Q3 737,896 $18,922,527 +$1,832,786 $25.64 13
2023 Q2 666,082 $17,724,300 -$118,275 $26.61 9
2023 Q1 675,342 $17,118,328 +$8,474,005 $25.35 11
2022 Q4 341,041 $8,228,441 +$1,684,703 $24.13 6
2022 Q3 284,677 $6,373,214 -$2,438,651 $22.39 9
2022 Q2 393,602 $9,593,000 -$7,259,862 $24.36 9
2022 Q1 676,484 $20,155,000 +$2,152,771 $29.80 11
2021 Q4 604,226 $18,812,858 +$65,085 $31.13 10
2021 Q3 601,345 $19,055,000 -$590,002 $31.68 7
2021 Q2 619,965 $20,101,000 -$3,955,110 $32.42 8
2021 Q1 741,950 $23,040,000 +$21,990,852 $31.05 8
2020 Q4 33,786 $997,000 -$159,881 $29.51 1
2020 Q3 39,204 $930,000 +$9,511 $23.72 1
2020 Q2 38,823 $849,000 -$54,457 $22.04 2
2020 Q1 45,666 $846,000 +$50,214 $18.53 3
2019 Q4 42,963 $1,143,000 -$20,178 $26.61 2
2019 Q3 43,721 $1,074,000 +$714,841 $24.57 2
2019 Q2 14,617 $371,000 +$371,000 $25.38 1